Literature DB >> 15483284

Pulmonary arterial hypertension.

Harrison W Farber1, Joseph Loscalzo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483284     DOI: 10.1056/NEJMra035488

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  351 in total

1.  Autonomic activation links CNS oxygen toxicity to acute cardiogenic pulmonary injury.

Authors:  Ivan T Demchenko; S Yu Zhilyaev; A N Moskvin; Claude A Piantadosi; Barry W Allen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

2.  5-HT(2B) receptors are required for serotonin-selective antidepressant actions.

Authors:  S L Diaz; S Doly; N Narboux-Nême; S Fernández; P Mazot; S M Banas; K Boutourlinsky; I Moutkine; A Belmer; A Roumier; L Maroteaux
Journal:  Mol Psychiatry       Date:  2011-12-13       Impact factor: 15.992

Review 3.  Pulmonary veno-occlusive disease: a misnomer?

Authors:  Cindy R Miller
Journal:  Pediatr Radiol       Date:  2012-02-05

4.  Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.

Authors:  Aikaterini J Megalou; Chryssoula Glava; Dimitrios L Oikonomidis; Agapi Vilaeti; Maria G Agelaki; Giannis G Baltogiannis; Apostolos Papalois; Antonios P Vlahos; Theofilos M Kolettis
Journal:  Int J Clin Exp Med       Date:  2010-10-23

5.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

6.  Prognostic utility of right atrial emptying fractions in pulmonary arterial hypertension.

Authors:  Nathan W Brunner; Francois Haddad; Yukari Kobayashi; Andrew Hsi; John R Swiston; Kenneth G Gin; Roham T Zamanian
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

7.  Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.

Authors:  Helen Christou; Hannes Hudalla; Zoe Michael; Evgenia J Filatava; Jun Li; Minglin Zhu; Jose S Possomato-Vieira; Carlos Dias-Junior; Stella Kourembanas; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2017-12-06       Impact factor: 4.030

8.  Recapitulation of developing artery muscularization in pulmonary hypertension.

Authors:  Abdul Q Sheikh; Janet K Lighthouse; Daniel M Greif
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

9.  The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.

Authors:  Hyunsook Kang; Kang-Hyun Kim; Jisun Lim; You-Sun Kim; Jinbeom Heo; Jongjin Choi; Jaeho Jeong; YongHwan Kim; Seong Who Kim; Yeon-Mok Oh; Myung-Soo Choo; Jaekyoung Son; Su Jung Kim; Hyun Ju Yoo; Wonil Oh; Soo Jin Choi; Sei Won Lee; Dong-Myung Shin
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

Review 10.  Cellular Metabolism in Lung Health and Disease.

Authors:  Gang Liu; Ross Summer
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.